ZBIO Q4 2023 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena

ZBIOZenas BioPharma, Inc.

$1B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20M

Operating Income

-$25M

Net Income

-$25M

EPS (Diluted)

$-0.64

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$15M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$68M

Total Liabilities

$294M

Stockholders' Equity

-$226M

Cash & Equivalents

$57M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20M	$0	—
Operating Income	-$25M	-$19M	-30.5%
Net Income	-$25M	-$19M	-29.4%